Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?

27

description

Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?. Case 1: Introduction. Case 1: Imaging and Laboratory Results. Case 1: Imaging and Laboratory Results. Organ Function and Age. Decline in Lung Function With Age and Smoking. - PowerPoint PPT Presentation

Transcript of Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?

Page 1: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 2: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 3: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 4: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 5: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 6: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 7: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 8: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 9: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 10: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 11: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 12: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 13: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 14: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 15: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 16: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 17: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 18: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 19: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 20: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 21: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 22: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 23: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 24: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 25: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 26: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Page 27: Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?

Immune therapy in NSCLC

Immune therapy in NSCLC

Adjuvant! Online ! Online - NKIresearch.nki.nl/amaros/Symposium 2009/Adjuvant Online.pdf · 2009. 11. 13. · Adjuvant Adjuvant & MammaPrint MammaPrint (70-genen profiel) • Pooled

Adjuvant! Online ! Online - NKIresearch.nki.nl/amaros/Symposium 2009/Adjuvant Online.pdf · 2009. 11. 13. · Adjuvant Adjuvant & MammaPrint MammaPrint (70-genen profiel) • Pooled

Immune checkpoint inhibitors in NSCLC - OncologyPRO€¦ · Dxnot approved fordurvalumabin any setting Dxnot approved foravellumabin US/EU: any setting NSQ NSCLC EU: NSQ NSCLC Approved

Immune checkpoint inhibitors in NSCLC - OncologyPRO€¦ · Dxnot approved fordurvalumabin any setting Dxnot approved foravellumabin US/EU: any setting NSQ NSCLC EU: NSQ NSCLC Approved

ADJUVANT THERAPY IN OLDER ADULTS: NSCLC

ADJUVANT THERAPY IN OLDER ADULTS: NSCLC

Adjuvant therapy

Adjuvant therapy

Chemotherapy for (non-metastatic) rectal Adjuvant chemotherapy – the evidence cancer · 2019. 6. 7. · Optimal management of localized rectal cancer in older patients SIOG 2017

Chemotherapy for (non-metastatic) rectal Adjuvant chemotherapy – the evidence cancer · 2019. 6. 7. · Optimal management of localized rectal cancer in older patients SIOG 2017

Nsclc slide deck

Nsclc slide deck

Adjuvant s

Adjuvant s

Adjuvant Analgesics

Adjuvant Analgesics

Locally Advanced Nsclc

Locally Advanced Nsclc

NSCLC dengan bronkoskopi

NSCLC dengan bronkoskopi

NSCLC - Stage IV STAGE IVNSCLC. NSCLC - Stage IV NSCLC Main Drugs Stage IV NAVELBINE:The pivotal drug GEMZAR:Main competitor TAXOL:Still often prescribed.

NSCLC - Stage IV STAGE IVNSCLC. NSCLC - Stage IV NSCLC Main Drugs Stage IV NAVELBINE:The pivotal drug GEMZAR:Main competitor TAXOL:Still often prescribed.

Immunotherapy in NSCLC

Immunotherapy in NSCLC

AdJUVANT & NEOADJUVANT CHEMOTHERAPYyesimeralp.com/sunum/NSCLC-tedavide-yenilikler.pdfINT 119: pCR hastaların 45%’ine pnömonektomi yapılmış...! The concept of “downstaging”

AdJUVANT & NEOADJUVANT CHEMOTHERAPYyesimeralp.com/sunum/NSCLC-tedavide-yenilikler.pdfINT 119: pCR hastaların 45%’ine pnömonektomi yapılmış...! The concept of “downstaging”

Agricultural Spray Adjuvant Technology -Sorting Out the Adjuvant Puzzle-

Agricultural Spray Adjuvant Technology -Sorting Out the Adjuvant Puzzle-

Surgical Approach to NSCLC

Surgical Approach to NSCLC

Concurrent ChemoRT in NSCLC

Concurrent ChemoRT in NSCLC

Role of Induction and Adjuvant Therapy in Regionally Advanced / Resectable NSCLC

Role of Induction and Adjuvant Therapy in Regionally Advanced / Resectable NSCLC

Treatment of ALK Positive Advanced NSCLC · Treatment of ALK Positive Advanced NSCLC ... • First identified in NSCLC cells in 2007 ... Chemistry of ALK Tyrosine Kinase Inhibitors

Treatment of ALK Positive Advanced NSCLC · Treatment of ALK Positive Advanced NSCLC ... • First identified in NSCLC cells in 2007 ... Chemistry of ALK Tyrosine Kinase Inhibitors

Adjuvant Chemotherapy in Older Adults with Lung Cancer · Ajeet Gajra MD FACP Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY. Introduction: Early Stage NSCLC

Adjuvant Chemotherapy in Older Adults with Lung Cancer · Ajeet Gajra MD FACP Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY. Introduction: Early Stage NSCLC